Exploitation of the Streptomyces coelicolor A3(2) genome sequence for discovery of new natural products and biosynthetic pathways

Research output: Contribution to journalReview ArticleResearchpeer-review

72 Citations (Scopus)


Streptomyces, and related genera of Actinobacteria, are renowned for their ability to produce antibiotics and other bioactive natural products with a wide range of applications in medicine and agriculture. Streptomyces coelicolor A3(2) is a model organism that has been used for more than five decades to study the genetic and biochemical basis for the production of bioactive metabolites. In 2002, the complete genome sequence of S. coelicolor was published. This greatly accelerated progress in understanding the biosynthesis of metabolites known or suspected to be produced by S. coelicolor and revealed that streptomycetes have far greater potential to produce bioactive natural products than suggested by classical bioassay-guided isolation studies. In this article, efforts to exploit the S. coelicolor genome sequence for the discovery of novel natural products and biosynthetic pathways are summarized.

Original languageEnglish
Pages (from-to)219-232
Number of pages14
JournalJournal of Industrial Microbiology and Biotechnology
Issue number2
Publication statusPublished - Feb 2014
Externally publishedYes


  • Antibiotic
  • Nonribosomal peptide synthetase
  • Polyketide synthase
  • Siderophore
  • Terpene synthase

Cite this